This six-month multicenter study involving 180 poorly controlled type 1 diabetes patients aimed to assess the impact of Diabeo software combined with telemedicine support on HbA1c levels. Patients were divided into three groups. The study’s findings indicate notable improvements in metabolic control with the Diabeo system, offering potential benefits over conventional care. For detailed information, refer to the full study
